Investments
1About CBG Asset Management
CBG Capital is an Australian equities listed investment company (LIC) that listed on the ASX in December 2014 (ASX code: CBC). The purpose of the company is to provide investors with access to a listed investment vehicle that actively manages a portfolio of investments in listed Australian companies. CBG Capital aims to pay a growing stream of fully franked dividends twice per year.
Want to inform investors similar to CBG Asset Management about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest CBG Asset Management News
Jan 21, 2019
New Israeli Medical Technologies Fund Aims to Close $150 Million in Commitments by End of Year CBG Asset Management, an investment firm owned by U.K.-based businessman Vincent Tchenguiz, is one of the partners in the venture Tzally Greenberg 16:2021.01.19 ALIVE HealthTech Fund, a newly-established Israeli venture fund, is aiming to raise $50 million in commitments by the end of the quarter and $150 million by the end of 2019, according to Ascher Shmulewitz, chairman of Israeli cannabis company Therapix Biosciences Ltd. The fund is looking to invest in medical technologies, he said. The founding partners have committed $32 million to the fund. The new fund is a joint venture of Shmulewitz; Israeli health maintenance organization Maccabi Healthcare Services; Israeli medical centers chain Assuta; CBG Asset Management, an investment firm owned by U.K.-based businessman Vincent Tchenguiz; and Michel Habib, a former general partner at Israeli venture capital firm Agate Medical Investment, and Tchenguiz's representative in Israel.
CBG Asset Management Investments
1 Investments
CBG Asset Management has made 1 investments. Their latest investment was in Pi Therapeutics as part of their Series B on May 5, 2019.
CBG Asset Management Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/29/2019 | Series B | Pi Therapeutics | $19.7M | Yes | 2 |
Date | 5/29/2019 |
|---|---|
Round | Series B |
Company | Pi Therapeutics |
Amount | $19.7M |
New? | Yes |
Co-Investors | |
Sources | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
